Corpus Intelligence IC Memo — BAPTIST BEAUMONT HOSPITAL 2026-04-26 08:03 UTC
IC Memo — BAPTIST BEAUMONT HOSPITAL
Investment Committee Memorandum | TX | 348 beds | Grade C | EBITDA uplift $27.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BAPTIST BEAUMONT HOSPITAL

CCN 450346 | JEFFERSON, TX | 348 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BAPTIST BEAUMONT HOSPITAL is a 348-bed suburban community hospital in JEFFERSON, TX with $374.8M in net patient revenue and a 5.5% operating margin. The hospital serves a payer mix of 16.5% Medicare, 10.5% Medicaid, and 73.0% commercial.

Thesis: Platform Growth. Our ML models identify $27.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.5% to 12.9% (+736bps).

Net Revenue HCRIS$374.8M
Current EBITDA COMPUTED$20.7M
Operating Margin COMPUTED5.5%
Occupancy HCRIS52.4%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS14.6%
Distress Probability ML48.0%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
112
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 5.5% places it above the state median. Among 112 size-comparable peers (174-696 beds), the median margin is 4.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (174-696), prioritizing same-state peers. 112 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BAPTIST BEAUMONT HOSPITAL (Target)TX348$374.8M5.5%
SCOTT AND WHITE MEMORIAL HOSPITX616$1.85B-10.5%
CHILDRENS MEDICAL CENTER OF DATX377$1.56B10.3%
COOK CHILDRENS MEDICAL CENTERTX423$1.51B16.5%
CHI ST LUKES HEALTH BAYLOR MEDTX628$1.10B-9.5%
UNIVERSITY HEALTH SYSTEMTX657$1.10B-50.0%
TX HLTH HARRIS METHODIST HOSPITX653$1.03B4.1%
CHRISTUS MOTHER FRANCES HOSP-TTX518$971.6M-17.0%
MEDICAL CITY PLANOTX573$936.8M40.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $27.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$7.9M+210bp18mo
Cost to Collect4.5%2.5%$7.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$7.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.6M+122bp9mo
Clean Claim Rate88.0%96.0%$240K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$7.9M
Cost to Collect
$7.5M
Denial Rate Reduction
$7.4M
A/R Days Reduction
$4.6M
Clean Claim Rate
$240K
Total EBITDA Uplift$27.6M
Current EBITDA$20.7M
+ RCM Uplift+$27.6M
Pro Forma EBITDA$48.3M
Current Margin5.5%
Pro Forma Margin12.9%
WC Released (1x)$14.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$31.8M$412.4M12.95x66.9%
Base (11x exit)10.0x11.0x$31.8M$464.0M14.57x70.9%
Bull Case9.0x11.0x$28.7M$565.4M19.73x81.6%
Bull (12x exit)9.0x12.0x$28.7M$625.2M21.82x85.3%
Bear Case11.0x10.0x$35.0M$264.1M7.54x49.8%
Bear (11x exit)11.0x11.0x$35.0M$301.9M8.62x53.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 112 hospitals with 174-696 beds
  • Same-state prioritization (n=113)
  • Comp margins: P25=-8.0% / P50=4.6% / P75=14.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.